Cargando...

NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma

Background: Novel immune therapies targeting tumor specific antigens are being developed. Our purpose was to determine expression of the cancer testes antigen NY-ESO-1 in renal cell carcinoma (RCC), as NY-ESO-1 targeting approaches, particularly adoptive cell therapy, have not been evaluated in this...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Giesen, Eva, Jilaveanu, Lucia B., Parisi, Fabio, Kluger, Yuval, Camp, Robert L., Kluger, Harriet M.
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2014
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4170640/
https://ncbi.nlm.nih.gov/pubmed/24970819
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!